Tosk: Funding, Investors & Team (Oct 2026)
Tosk Incorporated is a biopharmaceutical company dedicated to improving the safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis, and psoriasis. Side effects limit the use and effectiveness of many of today's pharmaceutical products. Tosk employs proprietary methods to discover and develop new drugs that reduce or eliminate the adverse effects of existing pharmaceuticals while maintaining their efficacy. This approach not only improves upon proven treatment regimens but also has the potential to deliver these enhanced drugs to the medical community more quickly and with lower research and development costs than is typically required for an entirely new drug.
Tosk has raised $100k across 1 funding round on record, the most recent a Debt Financing of $100k announced in Sep 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tosk Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Tosk Funding Rounds
Tosk Founders and Leadership Team
Contact details for the Tosk team: 1 of 1 has an email address on file.
Start 14-day free trial →Tosk Funding Compared to Other Biotechnology Startups
Tosk's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tosk in Biotechnology and Sunnyvale
Companies Similar to Tosk
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Tosk Funding FAQs
What does Tosk do?
Tosk Incorporated is a biopharmaceutical company dedicated to improving the safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis, and psoriasis. Side effects limit the use and effectiveness of many of today's pharmaceutical products. Tosk employs proprietary methods to discover and develop new drugs that reduce or eliminate the adverse effects of existing pharmaceuticals while maintaining their efficacy. This approach not only improves upon proven treatment regimens but also has the potential to deliver these enhanced drugs to the medical community more quickly and with lower research and development costs than is typically required for an entirely new drug.
How much funding has Tosk raised?
Tosk has raised $100k across 1 round on record. The most recent is a Debt Financing of $100k announced in Sep 2022.
When did Tosk last raise funding?
Tosk's most recent funding round on record is a Debt Financing of $100k, announced in Sep 2022.
Who is the CEO of Tosk?
Brian Frenzel is listed as CEO at Tosk.
Where is Tosk headquartered?
Tosk is based in Sunnyvale, California, United States.
How many employees does Tosk have?
Tosk is in the 11-50 employee band.
How does Tosk's funding compare to other Biotechnology startups?
Tosk's latest round of $100k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Tosk Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tosk is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.